Obesity and healthcare resource utilization: results from Clinical Practice Research Database (CPRD)
- PMID: 30338111
- PMCID: PMC6180713
- DOI: 10.1002/osp4.291
Obesity and healthcare resource utilization: results from Clinical Practice Research Database (CPRD)
Abstract
Background/objectives: The economic burden of obesity and type 2 diabetes (T2D) rises with increasing prevalence. This study estimates the association between obesity, healthcare resource utilization (HCRU) and associated costs in individuals with/without T2D.
Subjects/methods: This observational cohort study used the United Kingdom Clinical Practice Research Datalink data. Between 1 January 2011 and 31 December 2015, total HCRU costs and individual component costs (hospitalizations, general practitioner contacts, prescriptions) were calculated for individuals linked to the Hospital Episodes Statistics database with/without T2D with normal weight, overweight, class I, II, III obesity.
Results: A total of 396,091 individuals were included. Increasing body mass index (BMI) was associated with increased HCRU costs. At each BMI category, costs were greater for individuals with than without T2D. Relative to normal BMI, increasing BMI was positively associated with increased HCRU costs, with similar magnitude regardless of T2D. The total HCRU cost for an individual with class III obesity was 1.4-fold (£3,695) greater than for normal weight.
Conclusion: In the United Kingdom, HCRU costs were positively associated with increasing BMI, irrespective of T2D status. The combination of T2D and obesity was associated with higher HCRU costs compared with individuals of the same BMI, without T2D. These findings suggest that prioritizing weight management programmes focused specifically on individuals with obesity and T2D may be more cost-effective than for those with obesity alone.
Keywords: Diabetes mellitus type 2; general practitioners; obesity; prescriptions.
Figures



Similar articles
-
Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.Curr Med Res Opin. 2022 Nov;38(11):1831-1840. doi: 10.1080/03007995.2022.2125259. Epub 2022 Sep 29. Curr Med Res Opin. 2022. PMID: 36134459
-
Obesity, cardiovascular risk and healthcare resource utilization in the UK.Eur J Prev Cardiol. 2021 Sep 20;28(11):1235-1241. doi: 10.1177/2047487320925639. Epub 2020 May 27. Eur J Prev Cardiol. 2021. PMID: 34551077
-
Association between weight loss and health care resource utilization in adults living with obesity: Evidence from a UK primary care database.Diabetes Obes Metab. 2023 Dec;25(12):3611-3620. doi: 10.1111/dom.15256. Epub 2023 Sep 10. Diabetes Obes Metab. 2023. PMID: 37691253
-
The economic burden of tuberous sclerosis complex in UK patients with renal manifestations: a retrospective cohort study in the clinical practice research datalink (CPRD).J Med Econ. 2016 Dec;19(12):1116-1126. doi: 10.1080/13696998.2016.1202254. Epub 2016 Jun 25. J Med Econ. 2016. PMID: 27310569
-
Healthcare Resource Utilization (HCRU) and Direct Medical Costs Associated with Long COVID or Post-COVID-19 Conditions: Findings from a Literature Review.J Mark Access Health Policy. 2025 Feb 12;13(1):7. doi: 10.3390/jmahp13010007. eCollection 2025 Mar. J Mark Access Health Policy. 2025. PMID: 39990183 Free PMC article. Review.
Cited by
-
Impact of Obesity on Outcomes of Emergency Department Visits for Cardiac Chest Pain: Insights From a Nationwide Emergency Department Study.Cureus. 2023 Sep 1;15(9):e44540. doi: 10.7759/cureus.44540. eCollection 2023 Sep. Cureus. 2023. PMID: 37790060 Free PMC article.
-
Analysis of Tirzepatide Acquisition Costs and Weight Reduction Outcomes in the United Kingdom: Insights from the SURMOUNT-1 Study.Adv Ther. 2025 Jun;42(6):2821-2832. doi: 10.1007/s12325-025-03194-8. Epub 2025 Apr 18. Adv Ther. 2025. PMID: 40251452 Free PMC article. Clinical Trial.
-
Diabetes and Obesity in Down Syndrome Across the Lifespan: A Retrospective Cohort Study Using U.K. Electronic Health Records.Diabetes Care. 2022 Sep 30;45(12):2892-9. doi: 10.2337/dc22-0482. Online ahead of print. Diabetes Care. 2022. PMID: 36178378 Free PMC article.
-
Body mass index and risk of obesity-related conditions in a cohort of 2.9 million people: Evidence from a UK primary care database.Obes Sci Pract. 2020 Dec 24;7(2):137-147. doi: 10.1002/osp4.474. eCollection 2021 Apr. Obes Sci Pract. 2020. PMID: 33841883 Free PMC article.
-
A Retrospective Analysis Examining the Impact of Coexisting Diabetes and Substance Use Disorder on Hospital Resource Utilization.Cureus. 2025 May 11;17(5):e83895. doi: 10.7759/cureus.83895. eCollection 2025 May. Cureus. 2025. PMID: 40502893 Free PMC article.
References
-
- Organization WH . Global Health Observatory (GHO) data – obesity 2017. http://www.who.int/gho/ncd/risk_factors/obesity_text/en/. Accessed 15 February 2018
-
- Kent S, Fusco F, Gray A, Jebb SA, Cairns BJ, Mihaylova B. Body mass index and healthcare costs: a systematic literature review of individual participant data studies. Obes Rev 2017; 18: 869–879. - PubMed
-
- International Diabetes Federation . IDF Diabetes Atlas, 8th edn, 2017. http://www.diabetesatlas.org/. Accessed 15 February 2018.
LinkOut - more resources
Full Text Sources